Glenmark Pharmaceuticals Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on August 11, 2011, inter alia, have approved the Dividend of Re. 0.40 per share of Re. 1 each (40%) on the Equity Share Capital of the Company for the financial year ended 2010-2011.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
